AnaBios' Series B Round

AnaBios raised a round of funding on June 01, 2016.

AnaBios provides human-based drug response profiles in advance of clinical trials. AnaBios' Phase X (human tissue-based ex-vivo drug development studies) enables decision making concerning compound se…

Articles about AnaBios' Series B Round: